HealthDay News — A Trump administration rule to force pharmaceutical companies to disclose the list prices of their drugs in television ads was blocked Monday by a federal judge.

The rule, meant to slow rising drug prices, would apply to any drug that costs more than $35 a month and was to take effect this week. Drug makers Merck, Eli Lilly, and Amgen sued in June to block the rule, The New York Times reported.

The Department of Health and Human Services exceeded its regulatory authority by trying to impose the requirement, Judge Amit P. Mehta, of U.S. District Court in the District of Columbia, ruled.

In his decision, Mehta wrote: “That policy very well could be an effective tool in halting the rising cost of prescription drugs. But no matter how vexing the problem of spiraling drug costs may be, H.H.S. cannot do more than what Congress has authorized. The responsibility rests with Congress to act in the first instance,” The Times reported.

The New York Times Article

Related Articles